H1 Influenza Vaccine Delivered by MIMIX MAP(Vaxess Technologies)(H1 Influenza Vaccine Delivered by MIMIX MAP(Vaxess Technologies))

概要

基本信息

药物类型

预防性疫苗

别名-

靶点-

作用机制

免疫刺激剂

治疗领域

感染呼吸系统疾病

在研适应症

流感病毒感染

非在研适应症-

原研机构

Vaxess Technologies, Inc.

在研机构

Vaxess Technologies, Inc.

非在研机构-

最高研发阶段临床1期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

1

项与 H1 Influenza Vaccine Delivered by MIMIX MAP(Vaxess Technologies) 相关的临床试验

NCT06125717 / Completed临床1期

A Phase 1, Randomized, Rater and Subject Blinded Placebo Controlled Study to Evaluate the Safety, Reactogenicity, Tolerability and Immunogenicity of a Standard and a Fractional Dose of H1 Influenza Vaccine Delivered by VX-103 (a MIMIX Microneedle Patch (MAP) System) in Healthy Adults ≥18-39 Years of Age

A Phase 1, Randomized, Rater and Participant Blinded Placebo Controlled Study to Evaluate the Safety, Reactogenicity, Tolerability and Immunogenicity of a Standard and a Fractional Dose of H1 Influenza Vaccine Delivered by VX-103 (a MIMIX Microneedle Array Patch (MAP) System) in Healthy Adults ≥18-39 Years of Age

开始日期2022-07-02

申办/合作机构

Vaxess Technologies, Inc.

[+3]

100 项与 H1 Influenza Vaccine Delivered by MIMIX MAP(Vaxess Technologies) 相关的临床结果

登录后查看更多信息

100 项与 H1 Influenza Vaccine Delivered by MIMIX MAP(Vaxess Technologies) 相关的转化医学

登录后查看更多信息

100 项与 H1 Influenza Vaccine Delivered by MIMIX MAP(Vaxess Technologies) 相关的专利（医药）

登录后查看更多信息

100 项与 H1 Influenza Vaccine Delivered by MIMIX MAP(Vaxess Technologies) 相关的药物交易

登录后查看更多信息